Ratings Corebridge Financial, Inc.

Equities

CRBG

US21871X1090

Market Closed - Nyse Other stock markets 01:30:02 02/05/2024 am IST			5-day change	1st Jan Change
26.76 ^USD	+0.75%		-1.47%	+23.55%

26/04	Corebridge Financial, Inc. Announces Board Changes	CI
15/04	Morgan Stanley Adjusts Corebridge Financial's Price Target to $28 From $26, Keeps Equalweight Rating	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company's profit outlook over the next few years is a strong asset.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company appears to be poorly valued given its net asset value.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
COREBRIDGE FINANCIAL, INC.	+23.55%	16.53B	-
AXA	+10.00%	76.32B	B-
METLIFE, INC.	+8.69%	50.69B	B+
AFLAC INCORPORATED	+2.51%	48.13B	B
MANULIFE FINANCIAL CORPORATION	+10.78%	42.08B	B+
PRUDENTIAL FINANCIAL, INC.	+8.28%	39.7B	B+
GENERALI	+19.86%	38.01B	B
SUN LIFE FINANCIAL INC.	+3.08%	29.79B	B
GREAT-WEST LIFECO INC.	-7.02%	27.63B	B-
PRUDENTIAL PLC	-20.54%	24.06B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes